Editas Medicine (EDIT) 10-Q2017 Q1 Quarterly report

Filed: 15 May 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: Academy, agent, Allergan, ally, ameliorate, American, annum, appointed, Article, ascending, background, bar, billion, Brexit, broker, buy, category, CDP, Circuit, clarified, classification, Concurrently, confer, Congential, Congressional, contractor, conventional, Conviction, coordinate, Corrupt, corruption, cycle, debarment, defective, depict, devise, discernible, disqualification, distinct, DuPont, electorate, enzyme, ERS, explain, fairly, fast, faster, FCPA, formally, framework, frequency, fulfill, goal, grew, Hematology, Howard, indemnification, Indictment, Iowa, IP, justified, knowledge, leaving, led, line, Lisbon, meant, neutrality, nonpublic, notified, Obama, ocular, official, ordinary, orphan, outset, participatory, pattern, Pioneer, plc, pocket, political, possessed, possession, preceding, prepay, problem, promissory, proportion, qualification, quantity, reconciling, recover, referenced, referendum, regime, Relief, restated, revoked, routine, rulemaking, scheme, screen, steering, straight, strict, subtenant, superior, TALE, tasked, Taxpayer, thousand, threshold, Tokyo, TRACR, treatable, Treaty, trillion, Trump, unavailable, unmet, unpaid, unsatisfactory, upstream, UTokyo, variable, Wageningen, withholding

Removed: aggregating, alongside, amortization, applicant, attain, Avalanche, break, calendar, carried, chromosomal, collateral, confirmed, contrast, conversion, credited, dispositive, endonuclease, escalating, estate, Feng, inducing, jointly, July, lesser, month, monthly, nominated, nuclease, par, preissuance, prompt, publically, real, reclassifying, represented, retroactively, reverse, split, strand, Supplemental, TALEN, Zhang

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

EDIT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of Editas Medicine, Inc. (the “Company”) for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of her or his knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 15, 2017	By:	/s/ Katrine S. Bosley
		Katrine S. Bosley
		President and Chief Executive Officer


Date: May 15, 2017	By:	/s/ Andrew A.F. Hack
		Andrew A.F. Hack, M.D., Ph.D.
		Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.